Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05866406

The Effect of Time-Restricted Eating in Cardiometabolic Health

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Cambridge University Hospitals NHS Foundation Trust · Academic / Other
Sex
All
Age
25 Years – 75 Years
Healthy volunteers
Accepted

Summary

Time-restricted eating (TRE) is a dietary manipulation that involves restricting food intake to 6-12 h/day with no energy intake the rest of the day. In rodents, TRE improves metabolic function without caloric restriction, potentially by activating nutrient sensing mechanisms and effects on circadian oscillations. However, an understanding of the effect of TRE on cardiometabolic health in people is not clear and few studies have evaluated this issue. Accordingly, the investigators propose to conduct a randomized controlled trial in people with obesity and prediabetes to determine the effect of 9 h TRE for 12 weeks, without a change in body weight, on key metabolic outcomes that are risk factors for cardiovascular disease (CVD): 1) multi-organ insulin sensitivity; 2) 24 h metabolic homeostasis and diurnal rhythm; and 3) adipose tissue and skeletal muscle biology. The proposed studies will elucidate the cardiometabolic implications of TRE in people with obesity and prediabetes.

Conditions

Interventions

TypeNameDescription
BEHAVIORALTime restricted eatingParticipants assigned to the TRE group will have to consume all their daily meals and snacks during a 9-hour window for 12 weeks.
BEHAVIORALExtended eating windowParticipants assigned to the control group will have to consume all their daily meals and snacks during a 14-hour window for 12 weeks.
BEHAVIORALHealthy dietParticipants will be provided nutrition education and counselling to follow a diet consistent with the existing guidelines for chronic disease prevention.

Timeline

Start date
2023-11-01
Primary completion
2028-06-30
Completion
2028-08-31
First posted
2023-05-19
Last updated
2025-11-24

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT05866406. Inclusion in this directory is not an endorsement.